Concourse Financial Group Securities, Inc. Catalyst Pharmaceuticals, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$15.19 - $21.35 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$14.68 - $16.92 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$13.18 - $17.11 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$11.78 - $17.29 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$11.69 - $15.02 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$11.69 - $15.02 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$11.5 - $18.08 $0 - $0
Q1 2023 May 15, 2023	BUY	$14.34 - $21.05 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$12.25 - $19.5 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$7.06 - $15.52 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$6.23 - $8.57 $0 - $0
Q1 2022 May 09, 2022	BUY	$5.31 - $8.31 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$5.21 - $7.45 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$4.85 - $6.04 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$4.29 - $6.05 $0 - $0
Q1 2021 May 13, 2021	BUY	$3.45 - $4.69 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$2.97 - $3.83 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$2.97 - $5.08 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$3.48 - $5.05 $0 - $0
Q1 2020 May 13, 2020	BUY	$2.61 - $5.21 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$3.67 - $5.7 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$3.89 - $7.43 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$2.7 - $6.11 $0 - $0
Q1 2019 May 15, 2019	BUY	$2.11 - $5.33 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$1.92 - $3.62 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$2.81 - $3.78 $0 - $0

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94.6M

Call Options Held

19.1K

Put Options Held

51.1K

Black Rock Inc. New York, NY

18.7M
Shares

$405 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

8.04M
Shares

$174 Million
0.0% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

6.23M
Shares

$135 Million
2.3% of portfolio
State Street Corp Boston, MA

5.69M
Shares

$123 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

3.02M
Shares

$65.5 Million
0.01% of portfolio

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.23B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account